Pregabalin
Who holds supplier records for Pregabalin? 43 organisations hold a current record for Pregabalin: an active US FDA Type II Drug Master File or a CEP. A further 10 organisations have only historical (inactive) DMF filings. 33 of them hold a valid EU Certificate of Suitability (34 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (33), China (7), Netherlands (1), Italy (1) and 1 other country (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Pregabalin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/pregabalin
Reading the evidence
- 43 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
33 of the 43 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 23 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Pregabalin expires 2 May 2027. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (43)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Pregabalin. Country is the organisation's recorded country, not necessarily the manufacturing site.
- CHANGZHOU PHARMACEUTICAL FACTORYChinaCEP Company GMP cert on recordActive DMF 22223, 39164 · latest filing Nov 2023
- HIKAL LTDIndiaCEP Company GMP cert on recordActive DMF 29688, 28663 · latest filing Aug 2015
- Intas Pharmaceuticals Ltd.IndiaCEP Company GMP cert on recordActive DMF 27839, 36519 · latest filing Nov 2021
- MSN PHARMACHEM PRIVATE LTDIndiaCEPActive DMF 25064, 22111 · latest filing Jun 2011
- OPTIMUS DRUGS PRIVATE LTDIndiaCEPActive DMF 30968, 34934 · latest filing Jun 2020
- Zhejiang Bamboo Pharmaceuticals Co.,LtdChinaCEPActive DMF 38102, 43043 · latest filing Dec 2025
- Zydus Lifesciences LimitedIndiaCEP Company GMP cert on recordActive DMF 27792, 32520 · latest filing Feb 2018
- Alembic Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 24292 · latest filing Sept 2010
- ALMELO PRIVATE LTDIndiaCEPActive DMF 33522 · latest filing Mar 2019
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 26387 · latest filing Sept 2012
- Aurisco Pharmaceutical Co.,ltdChinaCEP Company GMP cert on recordActive DMF 31406 · latest filing Mar 2017
- CHROMO LABORATORIES INDIA PRIVATE LTDIndiaCEPActive DMF 36966 · latest filing Aug 2023
- Divis LaboratoriesIndiaCEP Company GMP cert on recordActive DMF 30790 · latest filing Aug 2016
- Dr. Reddy's Laboratories Ltd.IndiaCEP Company GMP cert on recordActive DMF 35314, 30663 · latest filing Apr 2021
- Hetero Drugs LimitedIndiaCEP Company GMP cert on recordActive DMF 27354 · latest filing Jul 2013
- INNOVARE LABS PRIVATE LTDIndiaCEPActive DMF 34774 · latest filing Aug 2020
- Laurus Labs LimitedIndiaCEP Company GMP cert on recordActive DMF 31415 · latest filing May 2017
- MATRIX PHARMACORP PRIVATE LTDIndiaCEPActive DMF 22485 · latest filing Feb 2009
- MSN LIFE SCIENCES PRIVATE LIMITEDIndiaCEP Company GMP cert on recordActive DMF 33365 · latest filing Nov 2018
- SRINI PHARMACEUTICALS PRIVATE LIMITEDIndiaCEP Company GMP cert on recordActive DMF 24700 · latest filing Mar 2011
- TAPI NL BVNetherlandsCEPActive DMF 22242 · latest filing Dec 2008
- VASUDHA PHARMA CHEM LTDIndiaCEPActive DMF 32531 · latest filing Aug 2018
- Zhejiang Huahai Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 27955 · latest filing Feb 2014
- ALIVUS LIFE SCIENCES LTDIndia Company GMP cert on recordActive DMF 30273 · latest filing May 2016
- CTX LIFE SCIENCES PVT LTDIndiaActive DMF 26246 · latest filing Jul 2012
- Macleods Pharmaceuticals Ltd.India Company GMP cert on recordActive DMF 26317 · latest filing Aug 2012
- MAHI DRUGS PRIVATE LIMITEDIndiaActive DMF 39959 · latest filing Mar 2026
- OLON SPAItaly Company GMP cert on recordActive DMF 24196 · latest filing Sept 2010
- Piramal Pharma LimitedIndia Company GMP cert on recordActive DMF 28396 · latest filing Jun 2014
- Shijiazhuang Lonzeal Pharmaceuticals Co., Ltd.ChinaActive DMF 38575 · latest filing Jul 2023
- SOLARA ACTIVE PHARMA SCIENCES LTDIndia Company GMP cert on recordActive DMF 28123 · latest filing Mar 2014
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 22128 · latest filing Nov 2008
- Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd.ChinaActive DMF 29168, 42070 · latest filing Jun 2025
- Aalidhra Pharmachem Private LimitedIndiaCEP
- IndiaCEP
- ENANTI LABS PRIVATE LIMITEDIndiaCEP
- IndiaCEP
- IndiaCEP Company GMP cert on record
- ChinaCEP
- IndiaCEP Company GMP cert on record
- IndiaCEP Company GMP cert on record
- DONGBANG FUTURE TECH & LIFE CO., LTD.South KoreaCEPValid CEP holder (EDQM); not necessarily the manufacturer
- MAPS LABORATORIES PRIVATE LIMITEDIndiaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (34)
Certificates of Suitability on the EDQM register for Pregabalin, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 50 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| ZHEJIANG BAMBOO PHARMACEUTICALS CO.,LTD. Shaoxing | CN | CEP 2025-610 - Rev 01 Pregabalin, Process II | Nov 2026 | — |
| NINGBO MENOVO PHARMACEUTICAL CO., LTD. Ningbo | CN | CEP 2026-264 - Rev 00 Pregabalin | Oct 2026 | — |
| HIKAL LIMITED Bengaluru | IN | CEP 2016-181 - Rev 04 Pregabalin | Oct 2026 | Inspected Nov 2025 Switzerland |
| MSN PHARMACHEM PRIVATE LIMITED Sangareddy | IN | CEP 2015-324 - Rev 03 Pregabalin, Route code-PB, crystalline form-1, micronised, non-micronised, milled and non-milled | Oct 2026 | — |
| HETERO DRUGS LIMITED Hyderabad | IN | CEP 2016-296 - Rev 02 Pregabalin | Sept 2026 | — |
| TAPI NL B.V. Amsterdam | NL | CEP 2017-165 - Rev 03 Pregabalin | Sept 2026 | — |
| ZYDUS LIFESCIENCES LIMITED Vadodara | IN | CEP 2019-019 - Rev 02 Pregabalin, Form-I | Aug 2026 | — |
| DONGBANG FUTURE TECH & LIFE CO., LTD. Hwaseong-Si | KR | CEP 2018-148 - Rev 03 Pregabalin | Aug 2026 | — |
| DIVI'S LABORATORIES LIMITED Hyderabad | IN | CEP 2016-236 - Rev 01 Pregabalin | Aug 2026 | — |
| CTX LIFESCIENCES PRIVATE LIMITED Surat | IN | CEP 2016-328 - Rev 05 Pregabalin | Aug 2026 | — |
| SARACA LABORATORIES LIMITED Sangareddy | IN | CEP 2022-439 - Rev 01 Pregabalin | Aug 2026 | Inspected Dec 2024 Belgium |
| MSN LIFE SCIENCES PRIVATE LIMITED Kamareddy | IN | CEP 2019-050 - Rev 01 Pregabalin, Route Code – PBN, Micronised and non-micronised | Jul 2026 | — |
| MATRIX PHARMACORP PRIVATE LIMITED Sangareddy | IN | CEP 2023-223 - Rev 03 Pregabalin, PEA Process | Jul 2026 | — |
| AURISCO PHARMACEUTICAL CO., LTD. Tiantai | CN | CEP 2019-073 - Rev 03 Pregabalin, Process Code PREA, milled and sieved | Jul 2026 | Inspected Dec 2023 Germany |
| AALIDHRA PHARMACHEM PRIVATE LIMITED Nandesari | IN | CEP 2019-085 - Rev 04 Pregabalin | Jul 2026 | — |
| ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Taizhou | CN | CEP 2025-282 - Rev 01 Pregabalin, Process VI | Jul 2026 | Inspected May 2026 Italy |
| VIYASH SCIENTIFIC LIMITED Hyderabad | IN | CEP 2023-386 - Rev 02 Pregabalin | Jul 2026 | — |
| INTAS PHARMACEUTICALS LIMITED Ahmedabad | IN | CEP 2022-028 - Rev 03 Pregabalin, Process II, Milled, Form-I | Mar 2026 | — |
| ALEMBIC PHARMACEUTICALS LIMITED Vadodara | IN | CEP 2016-220 - Rev 01 Pregabalin | Feb 2026 | — |
| CHROMO LABORATORIES INDIA PRIVATE LIMITED Pashamylaram | IN | CEP 2023-298 - Rev 00 Pregabalin | Feb 2026 | — |
| KOPRAN RESEARCH LABORATORIES LIMITED Mumbai | IN | CEP 2018-080 - Rev 04 Pregabalin | Dec 2025 | — |
| DR. REDDY'S LABORATORIES LIMITED Hyderabad | IN | CEP 2020-024 - Rev 03 Pregabalin | Jul 2025 | — |
| ENANTI LABS PRIVATE LIMITED Anakapalli District | IN | CEP 2023-199 - Rev 00 Pregabalin | Apr 2025 | — |
| SRINI PHARMACEUTICALS PRIVATE LIMITED Choutuppal | IN | CEP 2018-169 - Rev 01 Pregabalin | Jan 2025 | Inspected Sept 2025 Sweden |
| ALMELO PRIVATE LIMITED Shabashpally Village | IN | CEP 2019-046 - Rev 04 Pregabalin | Dec 2024 | — |
| VASUDHA PHARMA CHEM LIMITED Hyderabad | IN | CEP 2018-072 - Rev 02 Pregabalin | Dec 2024 | — |
| LAURUS LABS LIMITED Hyderabad | IN | CEP 2017-266 - Rev 03 Pregabalin | Jul 2024 | — |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2016-135 - Rev 01 Pregabalin | Jan 2024 | — |
| OPTIMUS DRUGS PRIVATE LIMITED Hyderabad | IN | R0-CEP 2021-126 - Rev 00 Pregabalin, Route code: OP-PGN | Mar 2023 | — |
| ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Linhai | CN | R1-CEP 2016-189 - Rev 01 Pregabalin | Sept 2022 | — |
| MAPS LABORATORIES PRIVATE LIMITED Rafaleshwar | IN | R1-CEP 2015-370 - Rev 00 Pregabalin | Jul 2022 | — |
| Changzhou Pharmaceutical Factory Jiangsu Province | CN | R1-CEP 2016-141 - Rev 00 Pregabalin | Jun 2022 | — |
| MANGALAM DRUGS & ORGANICS LTD. Mumbai | IN | R0-CEP 2020-016 - Rev 00 Pregabalin | May 2022 | — |
| INNOVARE LABS PRIVATE LIMITED Visakhapatnam | IN | R0-CEP 2020-145 - Rev 00 Pregabalin | Nov 2021 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (10)
Organisations whose Type II DMFs for Pregabalin are no longer active. These show a past filing, not current supply.
Show all 10 historical records
- India · Inactive DMF 34473 · filed Feb 2020
- India · Inactive DMF 31929 · filed Dec 2017
- India · Inactive DMF 30517 · filed Apr 2016
- DIVI'S LABOTATORIES LTDInactive DMF 28306 · filed May 2014
- LUPIN MANUFACTURING SOLUTIONS LTDInactive DMF 26673 · filed Jan 2013
- India · Inactive DMF 26062 · filed May 2012
- MYLAN LABORATORIES LTDInactive DMF 25083 · filed Jun 2011
- Zhejiang Jiuzhou Pharmaceutical Co., Ltd.China · Inactive DMF 23342 · filed Nov 2009
- India · Inactive DMF 22925 · filed Jul 2009
- India · Inactive DMF 22330 · filed Dec 2008
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (197 listed products contain Pregabalin). The latest listed patent expires 2 May 2027. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Pregabalin is a medication used to treat epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. It works by decreasing the number of pain signals that are sent out by damaged nerves in the body.
Chemical identity
- IUPAC name
- (3S)-3-(aminomethyl)-5-methylhexanoic acid
- Canonical SMILES
- CC(C)C[C@@H](CC(=O)O)CN
- InChIKey
- AYXYPKUFHZROOJ-PEZBUJJGSA-N
- Synonyms
- Lyrica, Pregabalin oral solution, Pregabalin extended-release, Pregabalinum, Pregabalin
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Pregabalin?
43 organisations hold an active US FDA Type II Drug Master File or a CEP for Pregabalin: CHANGZHOU PHARMACEUTICAL FACTORY (China), HIKAL LTD (India), Intas Pharmaceuticals Ltd. (India), MSN PHARMACHEM PRIVATE LTD (India), OPTIMUS DRUGS PRIVATE LTD (India), Zhejiang Bamboo Pharmaceuticals Co.,Ltd (China), Zydus Lifesciences Limited (India) and Alembic Pharmaceuticals Limited (India), and 35 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Pregabalin Drug Master Files are active?
CHANGZHOU PHARMACEUTICAL FACTORY (DMF 22223, 39164), HIKAL LTD (DMF 29688, 28663), Intas Pharmaceuticals Ltd. (DMF 27839, 36519), MSN PHARMACHEM PRIVATE LTD (DMF 25064, 22111), OPTIMUS DRUGS PRIVATE LTD (DMF 30968, 34934), Zhejiang Bamboo Pharmaceuticals Co.,Ltd (DMF 38102, 43043), Zydus Lifesciences Limited (DMF 27792, 32520) and Alembic Pharmaceuticals Limited (DMF 24292) and 25 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Pregabalin records mean?
10 organisations have only inactive Type II DMFs for Pregabalin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Pregabalin have a European Certificate of Suitability?
Yes. 33 organisations hold a valid CEP for Pregabalin on the EDQM register, including ZHEJIANG BAMBOO PHARMACEUTICALS CO.,LTD. Shaoxing (CN), NINGBO MENOVO PHARMACEUTICAL CO., LTD. Ningbo (CN), HIKAL LIMITED Bengaluru (IN), MSN PHARMACHEM PRIVATE LIMITED Sangareddy (IN), HETERO DRUGS LIMITED Hyderabad (IN) and TAPI NL B.V. Amsterdam (NL) and 28 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Pregabalin?
Yes. The latest patent listed for an approved US product containing Pregabalin expires 2 May 2027, across 197 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Pregabalin supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Pregabalin?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.